37.20
+0.88
+(2.42%)
As of 3:29:02 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 5 | 10 | 11 |
| Avg. Estimate | 2.08B | 1.4B | 6.21B | 6.33B |
| Low Estimate | 2.05B | 1.38B | 6.17B | 6.13B |
| High Estimate | 2.15B | 1.42B | 6.27B | 6.49B |
| Year Ago Sales | 2.08B | 1.36B | 6.18B | 6.21B |
| Sales Growth (year/est) | 0.07% | 3.11% | 0.42% | 2.01% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 8FR.F | -- | -- | -- | -- |
| S&P 500 | 9.71% | 11.16% | 13.99% | 13.56% |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 1/21/2025 |
| Upgrade | UBS: Sell to Neutral | 12/10/2024 |
| Maintains | TD Cowen: Hold to Hold | 12/9/2024 |
| Downgrade | Wells Fargo: Overweight to Equal-Weight | 12/9/2024 |
| Upgrade | JP Morgan: Underweight to Neutral | 12/9/2024 |
| Maintains | Telsey Advisory Group: Market Perform to Market Perform | 12/9/2024 |